Litcius/Paper detail

Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC

Keiya Uriu, Yu Kaku, Yoshifumi Uwamino, Hiroshi Fujiwara, Fumitake Saito, Kei Sato

2024The Lancet Infectious Diseases22 citationsDOIOpen Access PDF

Topics & Concepts

ImmunityHumoral immunityVirologyImmunologyBiologyImmune systemSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAnimal Virus Infections Studies
Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC | Litcius